Volker M. Lauschke

机构：Karolinska University Hospital, Central South University, Karolinska Institutet, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Second Xiangya Hospital of Central South University, University of Tübingen · ORCID：0000-0002-1140-6204

发表论文 274 篇 · 总被引 11562 次 · h-index 55

代表论文

• Engineering biomimetic tissue barrier models on chips: From design and fabrication to applications in disease modeling and drug screening (2025 · Biomaterials · 被引 10)
• Primary Human Tissue Models for Metabolic Dysfunction‐Associated Liver Disease ‐ toward Streamlining Drug Discovery with Patient‐Derived Assays (2025 · Advanced Biology · 被引 8)
• Transcription factors of the Nuclear Factor I (NFI) family control hepatocyte differentiation and cytochrome P450 activity in human liver (2025 · Pharmacological Research · 被引 5)
• Facilitated DNA damage repair as an emerging therapeutic strategy for inflammatory and fibrotic diseases (2026 · RSC Chemical Biology · 被引 3)
• Integration of germline pharmacogenomic burden to predict fluoropyrimidine-related toxicity – A secondary analysis of the PREPARE trial (2025 · Oncogene · 被引 3)
• Inhibition of the type I interferon receptor pathway protects against muscle weakness induced by dermatomyositis serum (2026 · Annals of the Rheumatic Diseases · 被引 2)